Osteoarthritis Trial, Recruiting NCT07330999 Sponsor: Poznan University of Medical Sciences Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT07330999
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 65 years or older
  • People scheduled for hip surgery, either planned in advance or as an emergency (for example, hip fracture repair or hip replacement)
  • People whose overall health before surgery falls within a low-to-moderate risk range, as assessed by their anaesthetist (known as ASA physical status I–III; confirm with trial site if unsure what this means)
  • People whose surgical pain management plan already includes a specific nerve-blocking procedure called a PENG block
  • People who are able to describe their pain level using a simple numbered scale (0–10)
  • People who have given written consent to participate, or whose legal representative has done so on their behalf

Who may not be able to join:

  • People who are unable or unwilling to give informed consent to the trial
  • People with a known allergy, intolerance, or medical reason to avoid any of the study medications: ropivacaine, dexamethasone, or dexmedetomidine
  • People who already have nerve damage or a neurological condition affecting the leg or hip being treated
  • People with blood clotting problems, including certain abnormal blood test results or blood-thinning medication that cannot safely be paused before surgery (confirm specific thresholds with trial site)
  • People with a skin infection at or near the area where the nerve block needle would be inserted
  • People with seriously reduced liver or kidney function
  • People who have been taking opioid pain medication every day for more than 30 days before surgery
  • People with significant memory or thinking difficulties, or confusion, that would make it unreliable for them to report their pain level
  • People with a BMI (a measure of body weight relative to height) above 40, as this may make the ultrasound-guided procedure technically difficult
  • People who have already had a nerve block affecting the same area targeted by this surgery
  • People who are pregnant or breastfeeding
  • People who have taken part in another interventional clinical trial within the past 30 days

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Malgorzata Reysner, MD PhD, Poznan University of Medical Sciences

Phone: +48 61 873 83 03

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Poznan University of Medical Sciences
Registry
ClinicalTrials.gov
Start date
13 February 2026
Est. completion
1 January 2027

Where this trial is recruiting

🇵🇱 Poland

Primary endpoints

Time to First Rescue Analgesia

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov